Legal Representation
Attorney
Lynn M. Humphreys
USPTO Deadlines
Next Deadline
624 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20211026)
Due Date
October 26, 2027
Grace Period Ends
April 26, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 31, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Dec 31, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 31, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 26, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 10, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 10, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 21, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 20, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 20, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 20, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 20, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 2, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 2, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 2, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 2, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 2, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 24, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 19, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 18, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 31, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biological products and preparations for use in scientific research, namely, proteins, polypeptides, peptides, toxins, neurotoxin, antisera and inmmunotoxins, lipopolysaccharides, bacterial extracts, adjuvants; Cell culture media being bacterial cultures for laboratory use; Chemical analysis testing kits containing peptide substrates used in testing certain toxins and neurotoxins for laboratory use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
First Use Anywhere:
19830000
First Use in Commerce:
Sep 17, 2020
Class 042
chemical laboratories; chemical research; chemical, biochemical, biological and bacteriological research and analysis; biological research and analysis; research and development of pharmaceutical preparations and medicines as a contract development and manufacturing organization; Pharmaceutical drug development services in the fields of substance and drug product manufacturing as a contract development and manufacturing organization; consulting services in the fields of biotechnology, pharmaceutical research and development, biotherapeutics, and cellular science; biopharmaceutical product development services; Testing of pharmaceuticals, specifically, analytical development services for others in the fields of biotherapeutics and biological products; research and development services in the medical and pharmaceutical fields; services for the development and testing of pharmaceutical products; consulting services in the sectors of biotherapeutics, diagnostics and laboratory testing techniques; Pharmaceutical product development of biotherapeutic formulations comprised of live bacterial cultures, reagents and pharmaceutical products
First Use Anywhere:
19830000
First Use in Commerce:
Sep 17, 2020
Classification
International Classes
001
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"LABS"